ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Morning Stiffness"

  • Abstract Number: 0560 • ACR Convergence 2021

    Effectiveness, Safety, Quality of Life and Patient Satisfaction with Tofacitinib Treatment in Adult Patients with Rheumatoid Arthritis Under Routine Clinical Care: Second Interim Analysis of a German Non-Interventional, Prospective, Multi-Center Study

    Klaus Krüger1, Frank Behrens2, Ulrich Prothmann3, Thilo Klopsch4, Lisa Blindzellner5, Olaf Behmer5, Jürgen Jobst5, Pascal Klaus5, Thomas Meng5 and Peter-Andreas Löschmann5, 1Rheumatological Practice Center, Munich, Germany, 2CIRI/Rheumatology & Fraunhofer IME, Research Division Translational Medicine & Pharmacology, Goethe University Hospital, Frankfurt, Germany, 3Knappschaftsklinikum Saar, Püttlingen, Germany, 4Rheumatological Practice, Neubrandenburg, Germany, 5Pfizer Pharma GmbH, Berlin, Germany

    Background/Purpose: Tofacitinib is a Janus kinase inhibitor, which is orally applied and is approved for rheumatoid arthritis among other indications. ESCALATE-RA is the first prospective,…
  • Abstract Number: 1196 • ACR Convergence 2021

    Morning Stiffness Already Associates with Systemic Inflammation and Subclinical Joint Inflammation in the Pre-RA Phase of Arthralgia

    Doortje Krijbolder1, Fenne Wouters1, Elise van Mulligen2 and Annette H.M van der Helm-van Mil1, 1Leiden University Medical Center, Leiden, Netherlands, 2Erasmus Medical Center, Rotterdam, Netherlands

    Background/Purpose: Morning stiffness (MS) is characteristic for Rheumatoid Arthritis (RA) and associates with markers of systemic and local inflammation in RA-patients. In patients with arthralgia,…
  • Abstract Number: 1011 • ACR Convergence 2020

    Effectiveness, Safety and Quality of Life with Tofacitinib Treatment in Adult Patients with Rheumatoid Arthritis Under Routine Clinical Care: First Interim Results from a German Non-Interventional, Prospective, Multi-Center Study

    Frank Behrens1, Ulrich Prothmann2, Thilo Klopsch3, Ann-Dörthe Holst4, Lisa Blindzellner5, Olaf Behmer5, Pascal Klaus5, Thomas Meng5 and Peter-Andreas Löschmann5, 1CIRI/Rheumatology & Fraunhofer IME, Research Division Translational Medicine and Pharmacology, Goethe University Hospital, Frankfurt, Hessen, Germany, 2Knappschaftsklinikum Saar, Püttlingen, Saarland, Germany, 3Rheumatological Practice, Neubrandenburg, Mecklenburg-Vorpommern, Germany, 4Specialist Practice for General Medicine incl. Rheumatology and Acupuncture, Ludwigslust, Mecklenburg-Vorpommern, Germany, 5Pfizer Pharma GmbH, Berlin, Berlin, Germany

    Background/Purpose: Tofacitinib is an orally applied Janus kinase inhibitor, which is approved for rheumatoid arthritis (RA) treatment in the USA since 2012, so that ‘real…
  • Abstract Number: 1340 • ACR Convergence 2020

    Secukinumab Improves Pain, Morning Stiffness, Fatigue and Physical Function in Tumor Necrosis Factor Inhibitor-Naïve Patients with Non-Radiographic Axial Spondyloarthritis: Results from a Randomized Controlled Phase III Study

    Helena Marzo-Ortega1, Atul Deodhar2, Ricardo Blanco3, Hideto Kameda4, Alan Kivitz5, Denis Poddubnyy6, Marina Magrey7, Jianyuan Wang8, Sibylle Haemmerle8, Abhijit Shete8 and Juergen Braun9, 1The University of Leeds, Leeds Institute for Rheumatic and Musculoskeletal Medicine, NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK, Leeds, United Kingdom, 2Oregon Health & Science University, Portland, OR, 3Hospital University Marqués de Valdecilla, Santander, Spain, 4Toho University, Tokyo, Japan, 5Altoona Center for Clinical Research/Altoona Arthritis and Osteoporosis Center, Duncansville, PA, 6Charité – Universitätsmedizin Berlin, Berlin, Germany, 7Case Western Reserve University School of Medicine, Cleveland, OH, 8Novartis Pharma AG, Basel, Switzerland, 9Rheumazentrum Ruhrgebiet and Ruhr-University, 44649 Herne, Germany

    Background/Purpose: Patients with non-radiographic axial spondyloarthritis (nr-axSpA) suffer from comparable disease burden to patients with ankylosing spondylitis/radiographic axSpA (AS/r-axSpA), including inflammatory back pain, morning stiffness,…
  • Abstract Number: 1847 • ACR Convergence 2020

    Delayed and Immediate Release Prednisone Decrease Fatigue Comparably in Patients with Systemic Lupus Erythematosus

    Hope Rainey1, Kristy Bell1, Violeta Rus2, Daniel Wallace3, Claire Dykas1, Mary Mora1, Maggy Comberg1 and Peter Lipsky1, 1AMPEL BioSolutions LLC., Charlottesville, VA, 2University of Maryland School of Medicine, Baltimore, MD, 3Cedars-Sinai Medical Center/UCLA, Los Angeles, CA

    Background/Purpose: Morning stiffness and fatigue are common symptoms in patients with SLE. Increased cytokines and disturbed sleep patterns may contribute to morning symptoms and fatigue…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies